Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Katerina Grafanaki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology-Venereology, School of Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Climate Change, Pulmonary Fibrosis, Skin Diseases, Skin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 351 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fibrotic diseases of the skin and lung, such as systemic sclerosis, hypertrophic scars, keloids, and pulmonary fibrosis, share core molecular mechanisms despite their distinct anatomical settings. Central to their pathogenesis are persistent fibroblast activation, immune dysregulation, ECM remodeling, and failure of resolution pathways, all modulated by an ever-changing environment and epigenetic regulation. Increasing evidence reveals that chronic injury from air pollution, ultraviolet radiation, climate stressors, and occupational hazards accelerates fibroinflammatory remodeling across these barrier organs. Moreover, shared signaling networks, including TGF-β, IL-4/IL-13, Wnt/β-catenin, and epigenetic regulators like miR-21 and miR-29, suggest convergent fibrotic programs may be subject to cross-organ therapeutic targeting. This review integrates recent insights into the exposome’s role in driving fibrosis, highlights novel RNA- and epigenetic-based interventions, and evaluates the repurposing of antifibrotic agents approved for pulmonary disease within dermatologic contexts. We emphasize the emerging concept of fibrosis-aware precision medicine and propose a unifying framework to guide integrated therapeutic strategies. In the face of global climate change and rising environmental insults, a cross-organ perspective on fibrosis offers a timely and translationally relevant approach to addressing this growing burden on human health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology-Venereology, School of Medicine, University of Patras, 26504 Patras, Greece.
- Department of Biochemistry, School of Medicine, University of Patras, 26504 Patras, Greece.
- Department of Respiratory Medicine, School of Medicine, University Hospital of Patras, 26504 Patras, Greece.
ORCID-Profile: Katerina Grafanaki, Efstathia Pasmatzi
Zitieren
APA
Grafanaki, K., Maniatis, A., Sotiropoulou, V., Pasmatzi, E., & Tzouvelekis, A. (2025). Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178394
Vancouver
Grafanaki K, Maniatis A, Sotiropoulou V, Pasmatzi E, Tzouvelekis A. Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178394
BibTeX
@article{Grafanaki2025,
author = {Grafanaki, Katerina and Maniatis, Alexandros and Sotiropoulou, Vasilina and Pasmatzi, Efstathia and Tzouvelekis, Argyris},
title = {Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178394}
}
EUVIMED